These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 16365449)

  • 1. Identification and characterization of U83A viral chemokine, a broad and potent beta-chemokine agonist for human CCRs with unique selectivity and inhibition by spliced isoform.
    Dewin DR; Catusse J; Gompels UA
    J Immunol; 2006 Jan; 176(1):544-56. PubMed ID: 16365449
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of HIV-1 infection by viral chemokine U83A via high-affinity CCR5 interactions that block human chemokine-induced leukocyte chemotaxis and receptor internalization.
    Catusse J; Parry CM; Dewin DR; Gompels UA
    Blood; 2007 May; 109(9):3633-9. PubMed ID: 17209056
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of CCR2+ human proinflammatory monocytes by human herpesvirus-6B chemokine N-terminal peptide.
    Clark DJ; Catusse J; Stacey A; Borrow P; Gompels UA
    J Gen Virol; 2013 Jul; 94(Pt 7):1624-1635. PubMed ID: 23535574
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CCR5 signalling, but not DARC or D6 regulatory, chemokine receptors are targeted by herpesvirus U83A chemokine which delays receptor internalisation via diversion to a caveolin-linked pathway.
    Catusse J; Clark DJ; Gompels UA
    J Inflamm (Lond); 2009 Jul; 6():22. PubMed ID: 19643012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Selective recruitment of Th2-type cells and evasion from a cytotoxic immune response mediated by viral macrophage inhibitory protein-II.
    Weber KS; Gröne HJ; Röcken M; Klier C; Gu S; Wank R; Proudfoot AE; Nelson PJ; Weber C
    Eur J Immunol; 2001 Aug; 31(8):2458-66. PubMed ID: 11500830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemokine receptor expression and function in CD4+ T lymphocytes with regulatory activity.
    Sebastiani S; Allavena P; Albanesi C; Nasorri F; Bianchi G; Traidl C; Sozzani S; Girolomoni G; Cavani A
    J Immunol; 2001 Jan; 166(2):996-1002. PubMed ID: 11145678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of experimental autoimmune encephalomyelitis: effect of altered peptide ligand on chemokine and chemokine receptor expression.
    Fischer FR; Santambrogio L; Luo Y; Berman MA; Hancock WW; Dorf ME
    J Neuroimmunol; 2000 Oct; 110(1-2):195-208. PubMed ID: 11024550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of chemokines and chemokine receptors during human renal transplant rejection.
    Segerer S; Cui Y; Eitner F; Goodpaster T; Hudkins KL; Mack M; Cartron JP; Colin Y; Schlondorff D; Alpers CE
    Am J Kidney Dis; 2001 Mar; 37(3):518-31. PubMed ID: 11228176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diverging binding capacities of natural LD78beta isoforms of macrophage inflammatory protein-1alpha to the CC chemokine receptors 1, 3 and 5 affect their anti-HIV-1 activity and chemotactic potencies for neutrophils and eosinophils.
    Struyf S; Menten P; Lenaerts JP; Put W; D'Haese A; De Clercq E; Schols D; Proost P; Van Damme J
    Eur J Immunol; 2001 Jul; 31(7):2170-8. PubMed ID: 11449371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of C-C chemokine receptors 1 and 5 and CCL3/macrophage inflammatory protein-1alpha in the cutaneous Arthus reaction: possible attenuation of their inhibitory effects by compensatory chemokine production.
    Yanaba K; Mukaida N; Matsushima K; Murphy PM; Takehara K; Sato S
    Eur J Immunol; 2004 Dec; 34(12):3553-61. PubMed ID: 15517609
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential recognition and scavenging of native and truncated macrophage-derived chemokine (macrophage-derived chemokine/CC chemokine ligand 22) by the D6 decoy receptor.
    Bonecchi R; Locati M; Galliera E; Vulcano M; Sironi M; Fra AM; Gobbi M; Vecchi A; Sozzani S; Haribabu B; Van Damme J; Mantovani A
    J Immunol; 2004 Apr; 172(8):4972-6. PubMed ID: 15067078
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Selective recruitment of CCR4-bearing Th2 cells toward antigen-presenting cells by the CC chemokines thymus and activation-regulated chemokine and macrophage-derived chemokine.
    Imai T; Nagira M; Takagi S; Kakizaki M; Nishimura M; Wang J; Gray PW; Matsushima K; Yoshie O
    Int Immunol; 1999 Jan; 11(1):81-8. PubMed ID: 10050676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunomodulation by herpesvirus U51A chemokine receptor via CCL5 and FOG-2 down-regulation plus XCR1 and CCR7 mimicry in human leukocytes.
    Catusse J; Spinks J; Mattick C; Dyer A; Laing K; Fitzsimons C; Smit MJ; Gompels UA
    Eur J Immunol; 2008 Mar; 38(3):763-77. PubMed ID: 18286574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of chemokine receptors CCR1 and CCR5 reflects differential activation of mononuclear phagocytes in pattern II and pattern III multiple sclerosis lesions.
    Mahad DJ; Trebst C; Kivisäkk P; Staugaitis SM; Tucky B; Wei T; Lucchinetti CF; Lassmann H; Ransohoff RM
    J Neuropathol Exp Neurol; 2004 Mar; 63(3):262-73. PubMed ID: 15055450
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Human CC chemokine liver-expressed chemokine/CCL16 is a functional ligand for CCR1, CCR2 and CCR5, and constitutively expressed by hepatocytes.
    Nomiyama H; Hieshima K; Nakayama T; Sakaguchi T; Fujisawa R; Tanase S; Nishiura H; Matsuno K; Takamori H; Tabira Y; Yamamoto T; Miura R; Yoshie O
    Int Immunol; 2001 Aug; 13(8):1021-9. PubMed ID: 11470772
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminooxypentane addition to the chemokine macrophage inflammatory protein-1alpha P increases receptor affinities and HIV inhibition.
    Townson JR; Graham GJ; Landau NR; Rasala B; Nibbs RJ
    J Biol Chem; 2000 Dec; 275(50):39254-61. PubMed ID: 11005816
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4.
    Ramos CD; Canetti C; Souto JT; Silva JS; Hogaboam CM; Ferreira SH; Cunha FQ
    J Leukoc Biol; 2005 Jul; 78(1):167-77. PubMed ID: 15831559
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HHV8-encoded vMIP-I selectively engages chemokine receptor CCR8. Agonist and antagonist profiles of viral chemokines.
    Dairaghi DJ; Fan RA; McMaster BE; Hanley MR; Schall TJ
    J Biol Chem; 1999 Jul; 274(31):21569-74. PubMed ID: 10419462
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition by IL-12 and IFN-alpha of I-309 and macrophage-derived chemokine production upon TCR triggering of human Th1 cells.
    Iellem A; Colantonio L; Bhakta S; Sozzani S; Mantovani A; Sinigaglia F; D'Ambrosio D
    Eur J Immunol; 2000 Apr; 30(4):1030-9. PubMed ID: 10760790
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Selective CC chemokine receptor expression by central nervous system-infiltrating encephalitogenic T cells during experimental autoimmune encephalomyelitis.
    Fife BT; Paniagua MC; Lukacs NW; Kunkel SL; Karpus WJ
    J Neurosci Res; 2001 Nov; 66(4):705-14. PubMed ID: 11746391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.